TrialThe lancet. HIV2025

Effects of antiretrovirals on major adverse cardiovascular events in the REPRIEVE trial: a longitudinal cohort analysis.

Carl J Fichtenbaum et al.PubMed ↗Full text ↗Publisher ↗

It states no comparison between the randomised groups of NCT02344290. The trial’s primary report, PMID 37486775, speaks for it on the map; the numbers here are shown and do not vote.

No numbers read from the abstract.